Professional Reference articles are designed for health professionals to use. They are written by UK doctors and based on research evidence, UK and European Guidelines. You may find the Epilepsy and Seizures article more useful, or one of our other health articles.
Treatment of almost all medical conditions has been affected by the COVID-19 pandemic. NICE has issued rapid update guidelines in relation to many of these. This guidance is changing frequently. Please visit https://www.nice.org.uk/covid-19 to see if there is temporary guidance issued by NICE in relation to the management of this condition, which may vary from the information given below.
Synonyms: salaam spasms
What is West syndrome?
The syndrome was classically described by Dr W J West in a letter to the editor of The Lancet in 1841. He described the events as:
'... bobbings that cause a complete heaving of the head forward towards his knees, and then immediately relaxing into the upright position ... these bowings and relaxings would be repeated alternately at intervals of a few seconds, and repeated from 10 to 20 or more times at each attack, which attack would not continue more than 2 or 3 minutes; he sometimes has 2, 3 or more attacks in the day.'
Today, West syndrome is classified as having three components, although diagnosis can still be made in the absence of one:
- Infantile spasms.
- Hypsarrhythmia (classical very abnormal electroencephalograph (EEG) that occurs even between attacks).
- General learning disability.
How common is West syndrome? (Epidemiology)
Infantile spasm is a rare disorder with an incidence of 1.6-4.5 per 10,000 live births, which is approximately 2,000-2,500 new cases per year in the USA. The peak incidence is between 4 and 7 months of age, with 90% starting under 1 year of age. It is confined to infants and very small children and is found equally across different ethnic groups. A small number have idiopathic infantile spasms with normal growth and development prior to the onset of infantile spasms, and no known aetiology.
West syndrome causes (aetiology)
West syndrome can be described as one phenotype with a variety of causes. Causes can be divided into symptomatic or idiopathic.
Almost any disorder that can produce brain damage can be associated with infantile spasms.
- Prenatal conditions (including hydrocephalus, microcephaly, Sturge-Weber syndrome, tuberous sclerosis); genetic syndromes (such as Aicardi's syndrome and Down's syndrome), hypoxic or ischaemic brain damage, congenital infections, and trauma.
- Perinatal disorders include hypoxia or ischaemia of the brain, meningitis, encephalitis, trauma and intracranial haemorrhage.
- Postnatal disorders include pyridoxine dependency, maple syrup urine disease, phenylketonuria, meningitis, degenerative diseases, biotinidase deficiency, and trauma.
Idiopathic (or cryptogenic)
Idiopathic infantile spasms are diagnosed if normal psychomotor development precedes the onset of symptoms, no underlying disorders or definite presumptive causes are present and no neurological or neuroradiological abnormalities exist. Some people use the terms 'idiopathic' and 'cryptogenic' as synonymous.
Spasms begin with a sudden, rapid, tonic contraction of the trunk and limb muscles, with gradual relaxation over 0.5 to 2 seconds. Contractions can last 5 or 10 seconds. They may range from a gentle nodding of the head to a powerful movement of the body.
- The spasms tend to occur in clusters. There may be dozens of them with a lapse of 5 to 30 seconds between each. They tend to occur just before sleep or on awaking. They can occur in sleep but this is unusual.
- Spasms can be flexor, extensor, or a mixture of both.
- Flexor spasms consist of brief contractions of the flexor muscles of the neck, trunk and limbs, causing a brief jerk. They may resemble a self-hugging motion and often there is a cry. The child relaxes and the jerk repeats. These attacks occur in clusters throughout the day and last anywhere from less than 1 minute to 10 or 15 minutes, or more in some patients.
- Extensor spasms are contractions of the extensor muscles, with sudden extension of the neck and trunk with extension and abduction of the limbs.
- Mixed spasms are the most common type, with flexion of the neck and arms with extension of the legs, or flexion of the legs with extension of the arms.
- Various series give the incidence of mixed spasms as around 40-50%, flexor spasms at about 35-40% and extensor spasms at 20-25%.
Between 70% and 90% have psychomotor delay or reversal. Physical examination usually reveals no abnormality, although it may help with an underlying diagnosis like the adenoma sebaceum of tuberous sclerosis.
- Examination with Wood's lamp is often helpful to see the hypopigmented skin lesions of this condition.
- Mild to moderate growth restriction is common.
- Neurological examination reveals nothing pathognomonic, although there may be vague and nonspecific features reflecting brain damage, and the effect of fits or medication.
- Ophthalmic examination may reveal evidence of one of the syndromes associated with the condition.
- Blood tests include FBC, LFTs, renal function, glucose, calcium, magnesium and phosphate.
- Blood cultures, urine examination and cerebrospinal fluid analysis if infection is suspected.
- Urine amino acids and organic acids and serum biotinidase.
- Brain MRI has the highest yield initial study in determining the aetiology in infantile spasms.
- EEG is essential, as hypsarrhythmia is crucial to the diagnosis:
- A prolonged study to obtain waking and sleeping traces may be required.
- Hypsarrhythmia is a characteristic interictal pattern of chaotic, high to extremely high-voltage polymorphic delta and theta rhythms with superimposed multifocal spikes and wave discharges.
- Multiple variations of this pattern are possible, including focal or asymmetric hypsarrhythmia.
- The ictal pattern has 11 different variations, although one is present in about 40%.
- There is no correlation between the ictal patterns and the type of fit.
This is aimed at control of seizures, with the fewest side-effects and the best quality of life. Adrenocorticotropic hormone (ACTH), prednisolone and vigabatrin have the best evidence as first-line medications.
First-line of treatment
- ACTH: this is effective in about 50-65% of cases. It involves a daily intramuscular (IM) injection. The precise dose is not established, although it seems that adding anti-epilepsy medication may have more side-effects with no increased efficacy.
- Prednisolone may be useful due to its low cost, ready availability, ease of administration, and growing evidence that it may be similar in efficacy to ACTH .ACTH and steroid treatment appear superior to vigabatrin (except in cases with tuberous sclerosis).
- Vigabatrin: this has a success rate of about 50%; however, vigabatrin is the treatment of choice in tuberous sclerosis.
- Several other anti-epileptic drugs (levetiracetam, nitrazepam, sodium valproate, topiramate, zonisamide) may be considered as adjuncts.
- In a few patients that are refractory to standard treatments, resection of part of the brain can give relief, especially in tuberous sclerosis or where there is a focal, structural abnormality.
- A ketogenic diet has shown good outcomes in some studies - 35% seizure-free after one month, but this diet is currently only recommended as an adjunct to other medications, or when medications have failed. .
There is research suggesting some social or ethnic groups receive non-standard treatments in the US healthcare system.
This very much depends on aetiology but the overall prognosis is poor with mortality rates from 3-33% reported. Additionally up to 60% of patients have moderate or severe neurodevelopmental delay after their spasms have stopped., The prognosis for idiopathic infantile spasms tends to be better than for symptomatic infantile spasms.
Early detection and prompt, effective treatment have been shown to improve neurodevelopmental outcomes, especially in idiopathic cases. However, the prognosis of infantile spasms in children with Down's syndrome and neurofibromatosis type I, is relatively good.
Further reading and references
Pestana Knight EM, Mani J; Historical Overview of Hypsarrhythmia and Its Association to Epileptic Spasms: A Review of the Medical Literature From 1952 to 1982. J Clin Neurophysiol. 2022 Nov 139(7):521-528. doi: 10.1097/WNP.0000000000000908. Epub 2022 Mar 24.
Smith MS, Matthews R, Mukherji P; Infantile Spasms.
Pavone P, Polizzi A, Marino SD, et al; West syndrome: a comprehensive review. Neurol Sci. 2020 Dec41(12):3547-3562. doi: 10.1007/s10072-020-04600-5. Epub 2020 Aug 22.
Yoshitomi S, Hamano SI, Hayashi M, et al; Current medico-psycho-social conditions of patients with West syndrome in Japan. Epileptic Disord. 2021 Aug 123(4):579-589. doi: 10.1684/epd.2021.1301.
Nelson GR; Management of infantile spasms. Transl Pediatr. 2015 Oct4(4):260-70. doi: 10.3978/j.issn.2224-4336.2015.09.01.
Romero Mila B, Remakanthakurup Sindhu K, Mytinger JR, et al; EEG biomarkers for the diagnosis and treatment of infantile spasms. Front Neurol. 2022 Jul 2813:960454. doi: 10.3389/fneur.2022.960454. eCollection 2022.
Ramantani G, Bolsterli BK, Alber M, et al; Treatment of Infantile Spasm Syndrome: Update from the Interdisciplinary Guideline Committee Coordinated by the German-Speaking Society of Neuropediatrics. Neuropediatrics. 2022 Dec53(6):389-401. doi: 10.1055/a-1909-2977. Epub 2022 Jul 26.
Fox JR, Guido-Estrada N, Williams K, et al; Outcomes among patients with infantile spasms treated with hormonal therapy and adjuvant topiramate versus hormonal therapy alone. Epileptic Disord. 2020 Feb 122(1):33-38. doi: 10.1684/epd.2020.1133.
Grinspan ZM, Knupp KG, Patel AD, et al; Comparative Effectiveness of Initial Treatment for Infantile Spasms in a Contemporary US Cohort. Neurology. 2021 Jul 1597(12):e1217-28. doi: 10.1212/WNL.0000000000012511.
Yuskaitis CJ, Mytinger JR, Baumer FM, et al; Association of Time to Clinical Remission With Sustained Resolution in Children With New-Onset Infantile Spasms. Neurology. 2022 Nov 2999(22):e2494-e2503. doi: 10.1212/WNL.0000000000201232. Epub 2022 Aug 29.
Mytinger JR, Albert DVF, Twanow JD, et al; Compliance With Standard Therapies and Remission Rates After Implementation of an Infantile Spasms Management Guideline. Pediatr Neurol. 2020 Mar104:23-29. doi: 10.1016/j.pediatrneurol.2019.11.016. Epub 2019 Dec 3.
Baumer FM, Mytinger JR, Neville K, et al; Inequities in Therapy for Infantile Spasms: A Call to Action. Ann Neurol. 2022 Jul92(1):32-44. doi: 10.1002/ana.26363. Epub 2022 Apr 28.
Widjaja E, Go C, McCoy B, et al; Neurodevelopmental outcome of infantile spasms: A systematic review and meta-analysis. Epilepsy Res. 2015 Jan109:155-62. doi: 10.1016/j.eplepsyres.2014.11.012. Epub 2014 Nov 22.